Alivion is an ETH spin-off that focuses on the product design, development, production and sale of proprietary gas sensing technology in food, environmental and health applications. Our vision is to create electronics with the sense of smelling.
Four Swiss medtechs mark commercial, regulatory and clinical milestones (startupticker.ch)
Swiss delegation set for VivaTech 2026 (startupticker.ch)
Three Swiss deep tech startups secure Eureka funding (startupticker.ch)
Swiss delegation warms up for CES 2026 in Las Vegas (startupticker.ch)
Four startups welcome new leaders to accelerate growth (startupticker.ch)
Ten startups to demo at the Mobile World Congress in Barcelona (startupticker.ch)
Venture Leaders Mobile 2025: The Mobile World Congress in Barcelona opens doors for ten high-potential Swiss startups (venturelab.swiss)
Strong startup delegation at Medica 2024 (startupticker.ch)
Alivion taps into the health market with breath analysis technology (startupticker.ch)
Alivion taps into the health market with breath analysis technology (startupticker.ch)
Alivion secures CHF 3.8 million to give mobile devices a sense of smell (startupticker.ch)
Applauses for Swiss Innovators (startupticker.ch)
ALIVION: Pilotversuch in Liberia (startupticker.ch)
First customers for Alivion’s methanol detector (startupticker.ch)
Seven deep tech start-ups receive CHF 100,000 each (startupticker.ch)
Top 10 W. A. de Vigier finalists nominated (startupticker.ch)